Naturally Splendid Signs Sales Distribution Agreement with Ecotrend Ecologics Cannabis Investing News
Algernon Receives First Ethics Approval for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia Pharmaceutical Investing
Algernon Pharmaceuticals Announces up to $5.0 Million Private Placement Offering of Special Warrants Pharmaceutical Investing
Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial Biotech Investing
Naturally Splendid Extends Filing Deadline for Annual Financial Statements and MD&A Cannabis Investing News
